Metronidazol Noridem

Metronidazole, the active ingredient in Metronidazol Noridem, is a nitroimidazole antibiotic presented as an injectable solution for intravenous use. It treats anaerobic bacterial and protozoal infections in adults and children as prescribed.

GNH USA supplies Metronidazol Noridem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metronidazole is employed to manage infections caused by anaerobic bacteria and certain protozoa. - Bacterial vaginosis: eliminates anaerobic organisms and restores normal vaginal flora. - Trichomoniasis: eradicates Trichomonas vaginalis, relieving symptoms and preventing recurrence. - Amoebic dysentery: kills Entamoeba histolytica trophozoites in intestinal tissue. - Clostridioides difficile infection: suppresses toxin‑producing C. difficile strains. - Anaerobic bacterial infections: targets a broad range of anaerobes in intra‑abdominal, pelvic, and soft‑tissue sites.

Metronidazole may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: transient gastrointestinal upset. - Metallic taste: persistent metallic sensation in the mouth. - Headache: mild to moderate intensity. - Diarrhea: loose stools during therapy. - Abdominal pain: cramping or discomfort.

Serious or Rare Side Effects: - Seizures: neurological events requiring immediate attention. - Peripheral neuropathy: tingling or numbness in extremities. - Severe allergic reactions: rash, swelling, or anaphylaxis. - Stevens‑Johnson syndrome: severe skin and mucous membrane involvement. - Hepatotoxicity: elevated liver enzymes or liver injury. - Neutropenia: reduced white blood cell count increasing infection risk.

Metronidazole requires careful consideration of patient‑specific factors before use. - Renal impairment: assess kidney function and adjust dosing if needed. - Hepatic dysfunction: monitor liver enzymes during therapy. - Alcohol consumption: avoid alcohol to prevent a disulfiram‑like reaction. - Pregnancy: use only when benefits outweigh potential risks. - Concurrent anticoagulants: monitor for enhanced bleeding tendency. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Metronidazole can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Alcohol: may cause severe disulfiram‑like reaction. - Warfarin: can increase anticoagulant effect and bleeding risk. - Lithium: may raise lithium levels leading to toxicity.

Moderate Interactions (Monitor Closely): - Cimetidine: may raise metronidazole plasma concentrations. - Phenobarbital: can reduce metronidazole effectiveness. - Oral contraceptives: may decrease hormonal contraceptive efficacy.